Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Animal cell – per se – expressing immunoglobulin – antibody – or...
Reexamination Certificate
2006-12-05
2006-12-05
Brumback, Brenda (Department: 1647)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Animal cell, per se, expressing immunoglobulin, antibody, or...
Reexamination Certificate
active
07144731
ABSTRACT:
Novel stem cell factors, oligonucleotides encoding the same, and methods of production, are disclosed. Pharmaceutical compositions and methods of treating disorders involving blood cells are also disclosed.
REFERENCES:
patent: 3898837 (1975-08-01), Boege
patent: 4275056 (1981-06-01), Takaku et al.
patent: 4338397 (1982-07-01), Gilbert et al.
patent: 4353242 (1982-10-01), Harris et al.
patent: 4438032 (1984-03-01), Golde et al.
patent: 4634665 (1987-01-01), Axel et al.
patent: 4695542 (1987-09-01), Yokota et al.
patent: 4703008 (1987-10-01), Lin
patent: 4714680 (1987-12-01), Civin
patent: 4721096 (1988-01-01), Naughton et al.
patent: 4722998 (1988-02-01), Cantor et al.
patent: 4808611 (1989-02-01), Cosman
patent: 4810643 (1989-03-01), Souza
patent: 4845078 (1989-07-01), Masaoka
patent: 4847325 (1989-07-01), Shadle et al.
patent: 4877729 (1989-10-01), Clark et al.
patent: 4879227 (1989-11-01), Clark et al.
patent: 4959314 (1990-09-01), Mark et al.
patent: 4959455 (1990-09-01), Clark et al.
patent: 4965204 (1990-10-01), Civin
patent: 5087570 (1992-02-01), Weissman et al.
patent: 5119315 (1992-06-01), Kemp et al.
patent: 5121337 (1992-06-01), Brown
patent: 5489516 (1996-02-01), Broudy et al.
patent: 5545533 (1996-08-01), Bartke et al.
patent: 5599703 (1997-02-01), Davis et al.
patent: 5620685 (1997-04-01), Nishi et al.
patent: 5641670 (1997-06-01), Treco et al.
patent: 5767074 (1998-06-01), Besmer et al.
patent: 5772992 (1998-06-01), Bauer et al.
patent: 5786323 (1998-07-01), Nakahata
patent: 5808002 (1998-09-01), Buhring
patent: 5919911 (1999-07-01), Broudy et al.
patent: 5935565 (1999-08-01), Besmer et al.
patent: 0 232 707 (1987-08-01), None
patent: 0 845 268 (1998-06-01), None
patent: 62-223126 (1987-10-01), None
patent: 8325294 (1996-12-01), None
patent: 62-107796 (1997-05-01), None
patent: 09154578 (1997-06-01), None
patent: WO 89/04452 (1989-05-01), None
patent: WO 92/03459 (1992-03-01), None
patent: WO 92/07074 (1992-04-01), None
patent: WO 93/21936 (1993-11-01), None
patent: WO 95/06112 (1995-03-01), None
patent: WO 95/28479 (1995-10-01), None
patent: WO 98/18924 (1998-05-01), None
patent: WO 98/23773 (1998-06-01), None
Broudy et al. Isolation and characterization of a monoclonal antibody that recognizes the human c-kit receptor. Blood 79(2): 338-345, 1992.
Lerner et al. Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood 77(9): 1876-1883, 1991.
Moore, G. Genetically engineered antibodies. Clin Chem 35(9): 1849-1853, 1989.
Ballow et al. Immunopharmacology, immunomodulation and immunotherapy. J Am Med Assoc 278(22: 2008-2017, 1997.
Rico-Vargas et al. c-kit expression by B cell precursors in mouse bone marrow. J Immunol 152: 2845-2852, 1994.
Cuthbert et al. Anti-interleukin-2 receptor monoclonal antibody (BT 563) in the treatment of severe acute GVHD refractory to systemic corticosteroid therapy. Bone Marrow Transplant. 10(5):451-455, 1992 (abstract only).
Scheinberg et al. A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide. J Clin Oncol. 9(3):478-490, 1991.
Kokai, Oct. 1, 1987, “Human hematopoietic stem cell growth factor-purification and characterization,” JP 62-223126, abstract.
Bodine et al., “Combination of Interleukins 3 and 6 Preserves Stem Cell Function in Culture and Enhances Retrovirus-Mediated Gene Transfer Into Hematopoietic Stem Cells,”Proc. Nat'l Acad. Sci., USA, 86:8897-8901 (1989).
Boswell et al., “A Novel Mast Cell Growth Factor (MCGF-3) Produced by Marrow-adherent Cells that Synergizes with Interleukin 3 and Interleukin 4,” Exp. Hematol., 18:794-800 (1990).
Bowie et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions,”Science, 247:1306-1310 (1990).
Broxmeyer et al., “Cell-Free Granulocyte Colony Inhibiting Activity Derived from Human Polymorphonuclear Neutrophils,”Exp. Hemat., 5:87-102 (1977).
Dexter, T.M., “Haemopoietic Growth Factors,” I, 45(2):337-349 (1989).
Dick et al., “Introduction of New Genes into Hematopoietic Stem Cells,”J. Cell. Biol., Supplement 11A, p. 187 (1987) (Abstract D 026).
Dick et al., “Introduction of Selectable Gene into Primitive Stem Cells Capable of Long-Term Reconstitution of the Hemopoietic Systme of W/WvMice,”Cell, 42:71-79 (1985).
Frömmel et al., “An Estimate of the Effect of Point Mutation and Natural Selection on the Rate of Amino acid Replacement in Proteins,”J. Mol. Evol., 21:233-257 (1985).
Fung et al., “Molecular cloning of cDNA for murine interleukin-3,”Nature, 307:233-237 (1984).
Gough et al., “Molecular Cloning of cDNA Encoding a Murine Haematopoietic Growth Regulator, Granulocyte-Macrophage Colony Stimulating Factor,”Nature, 309:763-767 (1984).
Grabbe, J. et al., “Stem Cell Factor, a Novel Cutaneous Growth Factor for Mast Cells and Melanocytes,”Arch. Dermatol. Res., 287:78-84 (1994).
Grichnik, J.M. et al., “The SCF/KIT Pathway Plays a Critical Role in the Control of Normal Human Melanocyte Homeostasis,”J. Invest. Dermatol., 111:233-238 (1998).
Hiraoka et al., “Further Characterization of the Biological Properties of Human Hematopoietic Survival and Growth Factor,”Expl. Cell. Biol., 57:27-34 (1989).
Hiraoka et al., “Production of Human Hematopoietic Survival and Growth Factor by a Myeloid Leukemia Cell Line (KPB-M15) and Placenta as Detected by a Monoclonal Antibody,”Cancer Research, 47:5025-5030 (1987).
Hiraoka et al., “Human Hematopoietic Survival and Growth Factor,”Cell Biology and International Reports, 10(5):347-355 (1986).
Hiraoka et al., “Monoclonal Antibodies Against Human Hematopoietic Survival and Growth Factor,”Biomed. Biochim. Acta, 46(5):419-427 (1987).
Hiraoka et al., “In Vitro Effect of Murine Peritoneal Exudate Cells Activated with a Streptococcal Preparation, OK-432, on Hematopoietic Stem Cells,”ACTA Hematol. Japan, 45:82-90 (1982).
Hiraoka et al., Cancer Research, 47(19):5025-5030 (1987); Abstract.
Hollands, “Differentiation of Embryonic Haemopoietic Stem Cells from Mouse Blastocysts Growth in Vitro,”Development, 102:135-141 (1988).
Humphries et al., “Aplastic Anemia and Stem Cell Biology,” inAplastic Anemia: Stem Cell Biology and Advances in Treatment, Alan R. Liss, Inc., New York, New York, pp. 3-12 (1984).
Jones et al., “Cyclic Hematopoiesis: Animal Models,”Exp. Hematol., 11:571-580 (1983).
Kamamoto et al., “Establishment of Two Ph1Chromosome-Positive Cell Lines, KPB-M8 and KPB-M15,”Jpn. J. Clin. Oncol., 16:107-115 (1986).
Kawasaki et al., “Molecular Cloning of a Complementary DNA Encoding Human Macrophage-Specific Colony-Stimulating Factor (CSF-1),”Science, 230:291-296 (1985).
King, R.C. et al., in A Dictionary of Genetics, Fifth Edition, Oxford University Press, p. 138 (Nov. 1996).
Kriegler et al., “Sources of Murine Macrophage Colony-Stimulating Factor that also Contain Growth Factors for Primitive Macrophage Progenitor Cells,”Exp. Hematol., 12:844-849 (1984).
Kriegler et al., “Partial Purification and Characterization of a Growth Factor for Macrophage Progenitor Cells with a High Proliferative Potential in Mouse Bone Marrow,”Blood, 60:503-508 (1982).
Langley et al., “Soluble Stem Cell Factor in Human Serum,”Blood, 81(3):656-660 (1993).
Lee et al., “Isolation of cDNA for a Human Granulocyte-Macrophage Colony-Stimulating Factor by Functional Expression in Mammalian Cells,”Proc. Natl. Acad. Sci., USA, 82:4360-4364 (1985).
Lev, S. et al., “Steel Factor and c-kit Protooncogene: Genetic Lessons in Signal Transduction,” Critical Reviews in Oncogenesis, 5:141-168 (1994).
Lewin, ed. Genes II, John Wiley & Sons, New York, p. 681 (1985).
Lyman et al., “Molecular Cloning of a Ligand for the flt3/flk-2 Tyrosine Kinase Receptor: A Proliferative Factor f
Bosselman Robert A.
Martin Francis H.
Suggs Sidney V.
Zsebo Krisztina M.
Amgen Inc.
Brumback Brenda
Bunner Bridget E.
Marshall & Gerstein & Borun LLP
LandOfFree
SCF antibody compositions and methods of using the same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with SCF antibody compositions and methods of using the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and SCF antibody compositions and methods of using the same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3676627